Cooper Gross Margin 2006-2018 | COO

Current and historical gross margin for Cooper (COO) over the last 10 years. The current gross profit margin for Cooper as of October 31, 2018 is %.
Cooper Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2018-10-31 $2.53B $1.63B 64.47%
2018-07-31 $2.44B $1.56B 63.69%
2018-04-30 $2.34B $1.49B 63.49%
2018-01-31 $2.23B $1.42B 63.86%
2017-10-31 $2.14B $1.37B 63.81%
2017-07-31 $2.10B $1.31B 62.40%
2017-04-30 $2.06B $1.27B 61.75%
2017-01-31 $2.02B $1.22B 60.68%
2016-10-31 $1.97B $1.17B 59.65%
2016-07-31 $1.91B $1.13B 59.37%
2016-04-30 $1.85B $1.09B 58.69%
2016-01-31 $1.80B $1.06B 58.57%
2015-10-31 $1.80B $1.07B 59.51%
2015-07-31 $1.81B $1.10B 60.61%
2015-04-30 $1.78B $1.11B 62.08%
2015-01-31 $1.76B $1.11B 62.89%
2014-10-31 $1.72B $1.09B 63.60%
2014-07-31 $1.66B $1.08B 64.78%
2014-04-30 $1.64B $1.06B 64.78%
2014-01-31 $1.61B $1.05B 65.03%
2013-10-31 $1.59B $1.03B 64.61%
2013-07-31 $1.57B $1.02B 64.57%
2013-04-30 $1.54B $0.99B 64.17%
2013-01-31 $1.50B $0.95B 63.64%
2012-10-31 $1.45B $0.92B 63.94%
2012-07-31 $1.41B $0.90B 63.48%
2012-04-30 $1.38B $0.86B 62.04%
2012-01-31 $1.36B $0.84B 61.56%
2011-10-31 $1.33B $0.81B 60.60%
2011-07-31 $1.28B $0.77B 59.98%
2011-04-30 $1.23B $0.74B 60.47%
2011-01-31 $1.19B $0.70B 59.03%
2010-10-31 $1.16B $0.68B 58.38%
2010-07-31 $1.13B $0.65B 57.45%
2010-04-30 $1.12B $0.62B 55.33%
2010-01-31 $1.09B $0.60B 55.46%
2009-10-31 $1.08B $0.60B 55.19%
2009-07-31 $1.06B $0.60B 56.30%
2009-04-30 $1.06B $0.61B 57.47%
2009-01-31 $1.06B $0.61B 57.67%
2008-10-31 $1.05B $0.61B 58.21%
2008-07-31 $1.03B $0.57B 54.91%
2008-04-30 $1.00B $0.56B 55.49%
2008-01-31 $0.97B $0.53B 54.90%
2007-10-31 $0.95B $0.52B 54.92%
2007-07-31 $0.91B $0.53B 58.05%
2007-04-30 $0.89B $0.52B 58.85%
2007-01-31 $0.87B $0.53B 60.44%
2006-10-31 $0.86B $0.53B 61.23%
2006-07-31 $0.86B $0.53B 61.69%
2006-04-30 $0.86B $0.53B 62.02%
2006-01-31 $0.87B $0.53B 61.73%
2005-10-31 $0.81B $0.50B 61.59%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $12.517B $2.533B
The Cooper Companies, Inc. is a global medical device company. Cooper is dedicated to being A Quality of Life Company with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of families with its diversified portfolio of products and services focusing on women's health, fertility and diagnostics.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $63.191B 21.47
McKesson (MCK) United States $24.096B 9.20
AmerisourceBergen (ABC) United States $17.637B 12.84
Align Technology (ALGN) United States $17.540B 44.75
Cardinal Health (CAH) United States $16.008B 10.75
Laboratory Of America Holdings (LH) United States $14.212B 12.86
Henry Schein (HSIC) United States $12.976B 21.33
DENTSPLY SIRONA (XRAY) United States $8.484B 16.94
West Pharmaceutical Services (WST) United States $7.982B 39.61
Merit Medical Systems (MMSI) United States $3.220B 38.14
Patterson (PDCO) United States $2.210B 16.86
CONMED (CNMD) United States $1.902B 31.59
STAAR Surgical (STAA) United States $1.600B 164.82
Atrion (ATRI) United States $1.430B 40.87
Antares Pharma (ATRS) United States $0.503B 0.00
Lifevantage (LFVN) United States $0.210B 29.74
Invacare (IVC) United States $0.173B 0.00
Endologix (ELGX) United States $0.067B 0.00
Pro-Dex (PDEX) United States $0.058B 25.77
Aceto (ACET) United States $0.045B 0.00
Retractable Technologies (RVP) United States $0.021B 0.00
Biolase (BIOL) United States $0.021B 0.00
Milestone Scientific (MLSS) United States $0.018B 0.00